Search Press releases

10 Oct 2024

Transparency notification BlackRock, Inc.

Read More
9 Oct 2024

Transparency notification BlackRock, Inc.

Read More
3 Oct 2024

Transparency notification BlackRock, Inc.

Read More
1 Oct 2024

Transparency notification BlackRock, Inc.

Read More
30 Sep 2024

Transparency notification BlackRock, Inc.

Read More
30 Sep 2024

UCB announces a head-to-head study evaluating BIMZELX[®]▼(bimekizumab) versus SKYRIZI® (risankizumab) in active psoriatic arthritis

Read More

Stay up-to-date on the latest news and information from UCB